University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Depression and anxiety symptoms at TNF inhibitor initiation are associated with impaired treatment response in axial spondyloarthritis

dc.contributor.authorZhao, Sizheng Steven
dc.contributor.authorJones, Gareth T
dc.contributor.authorHughes, David M
dc.contributor.authorMoots, Robert J
dc.contributor.authorGoodson, Nicola J
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Epidemiology Groupen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Arthritis and Musculoskeletal Health (ACAMH)en
dc.date.accessioned2021-12-10T13:48:01Z
dc.date.available2021-12-10T13:48:01Z
dc.date.issued2021-12
dc.descriptionAcknowledgment We are grateful to Professor Gary Macfarlane for commenting on the manuscript. We are grateful to the staff of the BSRBR-AS register and to the recruiting staff at the clinical centres, details of which are available at: www.abdn.ac.uk/bsrbr-as. We also thank Dr Lewis Carpenter for suggesting splines for modelling time. Contribution: SSZ analysed the data and wrote the manuscript with significant input from all co- authors. GTJ is the Deputy Chief Investigator on BSRBR-AS and designed the study and oversaw its conduct. In the current project they discussed results and provided input into drafts of the manuscript. Funding: The BSRBR-AS is funded by the British Society for Rheumatology (BSR) who have received funding for this from Pfizer, AbbVie and UCB. These companies receive advance copies of manuscripts for comments. They have no input in determining the topics for analysis or work involved in undertaking it.en
dc.description.statusPeer revieweden
dc.format.extent9
dc.format.extent454622
dc.identifier191493978
dc.identifier4eed212b-cfff-4d85-a42d-243e8ebc6170
dc.identifier33713118
dc.identifier85122546134
dc.identifier.citationZhao, S S, Jones, G T, Hughes, D M, Moots, R J & Goodson, N J 2021, 'Depression and anxiety symptoms at TNF inhibitor initiation are associated with impaired treatment response in axial spondyloarthritis', Rheumatology, vol. 60, no. 12, pp. 5734–5742. https://doi.org/10.1093/rheumatology/keab242en
dc.identifier.doi10.1093/rheumatology/keab242
dc.identifier.iss12en
dc.identifier.issn1462-0324
dc.identifier.otherORCID: /0000-0003-0016-7591/work/93483281
dc.identifier.urihttps://hdl.handle.net/2164/17659
dc.identifier.vol60en
dc.language.isoeng
dc.relation.ispartofRheumatologyen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectaxial spondyloarthritisen
dc.subjectdepressionen
dc.subjectmental healthen
dc.subjectanxietyen
dc.subjecttreatment responseen
dc.subjectR Medicineen
dc.subjectOtheren
dc.subjectSupplementary Dataen
dc.subject.lccRen
dc.titleDepression and anxiety symptoms at TNF inhibitor initiation are associated with impaired treatment response in axial spondyloarthritisen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Zhao_et_al_Depression_anxiety_Rheumatology_vor.pdf
Size:
443.97 KB
Format:
Adobe Portable Document Format

Collections